Dr. Sheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5330 E Stop 11 Rd
Indianapolis, IN 46237Phone+1 317-893-1900Fax+1 317-893-1901
Summary
- Dr. Calvin Sheng is an interventional & structural cardiologist in Indianapolis, IN. He received his medical degree from Vanderbilt University School of Medicine and has been in practice since 2015. He also speaks multiple languages, including Chinese (Mandarin). He specializes in interventional cardiology, structural cardiology, CHIP, and peripheral endovascular interventions. He has more than 20 publications and over 500 citings.
Education & Training
- Cleveland Clinic FoundationFellowship, Interventional Cardiology, 2022 - 2024
- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2019 - 2022
- Johns Hopkins UniversityResidency, Internal Medicine, 2016 - 2019
- Vanderbilt University School of MedicineClass of 2016, MD, AOA
- Duke UniversityBS, Biology, Magna Cum Laude, PKB, 2007 - 2011
Certifications & Licensure
- OH State Medical License 2019 - 2026
- IN State Medical License 2024 - 2025
- MD State Medical License 2016 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
- Certification Board of Nuclear Cardiology (CBNC)American Society of Nuclear Cardiology (ASNC)
- National Board of Echocardiography (NBE)American Society of Echocardiography (ASE)
- Registered Physician in Vascular Interpretations (RPVI)The Alliance for Physician Certification & Advancement (APCA)
Awards, Honors, & Recognition
- Alpha Omega Alpha 2016
- Sarnoff Cardiovascular Research Fellowship 2014-2015
- Phi Kappa Beta 2011
- Join now to see all
Clinical Trials
- Canakinumab in Covid-19 Cardiac Injury (The Three C Study) Start of enrollment: 2020 Apr 24
- Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation Start of enrollment: 2020 May 20
Publications & Presentations
PubMed
- Images in Vascular Medicine: Valsalva purpura secondary to balloon occlusion of the cavoatrial junction during intervention for lead-induced SVC syndrome.Calvin C Sheng, Bruce L Wilkoff, Sean P Lyden, Edward Soltesz, Scott J Cameron
Vascular Medicine. 2023-10-01 - Successful Endovascular Treatment of an Anastomotic Pseudoaneurysm in the Ascending Aorta.Calvin Chen Sheng, Adrian Santini, Frank H Annie, Muhammad Rawala, Deepak L Bhatt
The American Journal of Cardiology. 2023-09-15 - 4 citationsImpaired Reorganization of Centrosome Structure Underlies Human Infantile Dilated Cardiomyopathy.Young Wook Chun, Matthew Miyamoto, Charles H Williams, Leif R Neitzel, Maya Silver-Isenstadt
Circulation. 2023-04-25
Journal Articles
- 21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized MedicineSheng, C.C., L. Amiri-Kordestani, T. Palmby, T. Force, C.C. Hong, J. C. Wu, G. Kim, & J. Moslehi, JACC-BTS
Other Languages
- Chinese (Mandarin)
External Links
- LinkedInhttps://www.linkedin.com/in/calvin-sheng-78622568/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: